Here at Zacks, we don’t generally classify stocks as “cheap” or “expensive,” and rather than looking at the stock’s face value, we have a system that puts an emphasis on earnings estimate revisions to find stocks that will hopefully be winners for investors.That being said, low-priced stocks can be attractive to smaller investors that can’t necessarily afford large stakes in companies with higher priced stocks. When looking at these low-priced stocks, we can look at the same trends in growth, value, and momentum and apply the Zacks Rank to properly analyze the potential that these companies have.Today we’ve highlighted five stocks that are currently trading for under $10 per share. These stocks are also showing signs for solid growth throughout 2017, and all of them currently hold a Zacks Rank #1 (Strong Buy).1. Nobilis Health Corp. (HLTH)Prior Close: $1.90Nobilis Health Corp. is a regional healthcare facilities operator with several ambulatory surgery centers, acute care hospitals, imagining centers, and urgent care clinics in Texas and Arizona. The stock’s strong Zacks Rank has been lifted by recent its recent estimate revision activity, as we’ve seen one positive revision for the company’s current-quarter, full-year, and next-year earnings over the last 60 days. On top of this, HLTH looks fundamentally sound, which is evidenced by its overall VGM grade of “A.” Trend-focused investors will also note that the stock has “A” grades for Value and Growth. 2. Quantum Corporation (QTM)Prior Close: $8.01Quantum is a leading provider of data storage and protection. The company provides solutions for capturing, sharing, and preserving digital assets over the entire data lifecycle. The current fiscal year is shaping up to be one of aggressive earnings growth for Quantum; our current Zacks Consensus Estiamte calls for the company to post EPS growth of 96% this year. It’s also worth noting that the stock has been on an incredible run, gaining nearly 160% over the past year. Nevertheless, its previous closing price is about 13% lower than its 52-week high, which means there’s plenty of upside before we even have to think about breaking into a new range. 3. Sorl Auto Parts (SORL)Prior Close: $7.68Sorl Auto Parts is a China-based maker of air brake valves and hydraulic brake valves, which it sells to a wide range of vehicle manufacturers. SORL has been one of the hottest low-priced stocks on the market this year, primarily because of the company’s impressive earnings and sales growth. For the full year, our consensus estimates would reflect revenue growth of 16% and EPS growth of 29%. Furthermore, the company falls into a group of businesses that sit in the top 17% of the Zacks Industry Rank and the top 1% of the Zacks Sector Rank. Finally, with an “A” grade for Value in our Style Scores system, this stock could be a darling for value-focused investors. 4. Camtek Ltd. (CAMT)Prior Close: $4.83Camtek is a developer of automatic optical inspection systems that are used used to enhance both production processes and yield for manufacturers in the circuit board and semiconductor industries. Like many companies on this list, we expect the remainder of 2017 to be a year of aggressive earnings growth for Camtek, and overall, our current consensus estimates project EPS growth of nearly 112% this year. This earnings growth is also coming on the back of strong projected sales growth of 18%. Camtek has also recorded better-than-industry-average P/E and P/S ratios, and the stock has gained nearly 47% year-to-date, making it an interesting choice for a variety of trend-focused investors. 5. Tecogen Inc. (TGEN)Prior Close: $3.33Tecogen develops systems that produce electricity, hot water, and air conditioning for commercial installations and buildings and industrial processes. Although we expect the company to record a loss this year, its EPS figures are projected to grow by 33%. Looking ahead, Tecogen is expected to be profitable in the next fiscal year, a period where our consensus estimates are calling for earnings growth of 275%. This growth is boosted by projected sales growth of 23% and 28%, respectively. Additionally, Tecogen falls into a category of businesses that sit in the top 8% of the Zacks Industry Rank, and the stock is outshining its industry peers in several key growth categories. Bottom LineA stock’s market price is certainly not the most important factor to consider when considering whether or not to add it to your portfolio, and sales and earnings growth projections can prove to be tough to live up to.Nevertheless, we can always use Zacks’ proven methods of finding quality stocks, and these five companies just happen to be showing strength while also trading for under $10 per share. If you would like to check out more of these low-priced stocks, look no further than our Stocks Under $10 portfolio service!Want more market analysis from this author? Make sure to follow @https://twitter.com/Ryan_McQueeney!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+"://platform.twitter.com/widgets.js";fjs.parentNode.insertBefore(js,fjs);}}(document,"script","twitter-wjs"); on Twitter!Zacks' Best 1 to 3-Month Stocks at Any PriceYou are invited to download today's full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buys" free of charge. They come in all price-per-share ranges, and many are almost unheard of by the general public.These stocks have been pinpointed by the system that has more than doubled the market from 1988 through 2016 with a stunning average gain of +25% per year. Our Zacks Rank #1s have short-term profit horizons. See them now for free >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Quantum Corporation (QTM): Free Stock Analysis Report SORL Auto Parts, Inc. (SORL): Free Stock Analysis Report Tecogen Inc. (TGEN): Free Stock Analysis Report Camtek Ltd. (CAMT): Free Stock Analysis Report Nobilis Health Corp. (HLTH): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research